ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Fexofenadine Zentiva® 120/180 mg:Helvepharm AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
R06AX26 - FexofenadineATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R06 - Antihistamines for Systemic Use
 
R06A - Antihistamines for Systemic Use

This group comprises plain and combined antihistamine preparations for systemic use. Antihistamines used in motion sickness are classified in this group. Other preparations used in motion sickness, see A04 - Antiemetics and antinauseants.
See also N07C - Antivertigo preparations.
Combined preparations (incl. combinations with hydroxyzine) are classified at separate 5th levels using the corresponding 50-series.
Combinations of antihistamines are classified at a separate 4th level, R06AK.
Antihistamines are also included in combined preparations classified in other groups:
Combinations with analgesics - N02
Combinations with xanthines - R03DA
Combinations with leukotriene receptor antagonists - R03DC.
Combinations with expectorants - R05C
Combinations with nasal decongestants for systemic use - R01B
Combinations with cough suppressants - R05D
Allergen extracts, see V01.
The group is subdivided according to chemical structure.

For some of the substances, different dosage forms are given different DDDs, due to differences in bioavailability.

R06AX - Other Antihistamines for Systemic Use
 
R06AX26 - Fexofenadine
DoseRoute of administrationNote
 O 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home